Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.
<h4>Background</h4>Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be down regulated by immunotherapy.<h4>Obj...
Guardado en:
Autores principales: | Anna Maria Riccio, Daniele Saverino, Giampaola Pesce, Anthi Rogkakou, Maurizio Severino, Patrizia Bonadonna, Erminia Ridolo, Marina Mauro, Giorgio Walter Canonica, Marcello Bagnasco, Giovanni Passalacqua |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aedc9dbda2934a46937da33a83235dbf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
por: Rita Simone, et al.
Publicado: (2012) -
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life?
por: Fulvio Braido, et al.
Publicado: (2012) -
Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
por: Franziska Ruëff, et al.
Publicado: (2013) -
A Short Review of the Venoms and Toxins of Spider Wasps (Hymenoptera: Pompilidae)
por: Daniel Dashevsky, et al.
Publicado: (2021) -
Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Hsin-Yu Liu, et al.
Publicado: (2021)